Suppr超能文献

内镜下胆管支架置入术作为疑似Oddi括约肌功能障碍患者内镜下括约肌切开术后预后的预测指标。

Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction.

作者信息

Rolny P

机构信息

Department of Medicine, Ostra University Hospital Gothenburg, Sweden.

出版信息

Eur J Gastroenterol Hepatol. 1997 May;9(5):467-71. doi: 10.1097/00042737-199705000-00011.

Abstract

OBJECTIVES

To determine whether symptomatic improvement following placement of endoscopic stent across the biliary sphincter could predict the longer-term clinical outcome after endoscopic sphincterotomy (ES).

METHODS

Twenty-three post-cholecystectomy patients with suspected sphincter of Oddi dysfunction underwent, sequentially, sphincter of Oddi manometry, endoscopic stent placement, ES, and follow-up for a further 6-12 months.

RESULTS

Eight (35%) patients either did not respond (n = 5), did not tolerate the stent (n = 1) or relapsed during stenting (n = 2). Only the patient who did not tolerate the stent from the outset (12%) improved after ES. Of five patients who responded to stenting and had ES within 8 weeks, only two (40%) remained asymptomatic. In contrast, of 10 patients who were pain-free during 12-14 weeks of stenting, nine (90%) continued to be asymptomatic after ES. All seven patients with an elevated sphincter of Oddi pressure responded to stenting and six benefited from sphincter ablation. Five (31%) of 16 patients who had normal sphincter pressure and had improvement after 12-14 weeks of stenting remained free from pain following ES. ES resulted in long-term freedom from pain in 12 of the 23 patients: six of the seven patients with elevated sphincter of Oddi pressure and six of the 16 subjects with normal manometry (P < 0.05).

CONCLUSION

Freedom from symptoms during at least 12 weeks of stenting predicted a favourable outcome after ES, irrespective of sphincter of Oddi pressure. Patients who failed to improve or showed improvement only with short-term stenting were less likely to benefit.

摘要

目的

确定经内镜在胆道括约肌处放置支架后的症状改善情况是否可预测内镜下括约肌切开术(ES)后的长期临床结局。

方法

23例胆囊切除术后疑似Oddi括约肌功能障碍的患者依次接受了Oddi括约肌测压、内镜下支架置入、ES,并进行了为期6 - 12个月的随访。

结果

8例(35%)患者无反应(n = 5)、不耐受支架(n = 1)或在支架置入期间复发(n = 2)。仅1例从一开始就不耐受支架的患者(12%)在ES后有所改善。在5例对支架置入有反应且在8周内接受ES的患者中,仅2例(40%)仍无症状。相比之下,在10例在支架置入12 - 14周期间无疼痛的患者中,9例(90%)在ES后仍无症状。所有7例Oddi括约肌压力升高的患者对支架置入有反应,6例受益于括约肌切除术。16例括约肌压力正常且在支架置入12 - 14周后有所改善的患者中,5例(31%)在ES后仍无疼痛。ES使23例患者中的12例长期免于疼痛:7例Oddi括约肌压力升高的患者中有6例,16例测压正常的患者中有6例(P < 0.05)。

结论

至少12周的支架置入期间无症状可预测ES后的良好结局,与Oddi括约肌压力无关。未改善或仅短期支架置入有改善的患者受益的可能性较小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验